Carebios is a privately - owned, emerging pre - clinical CRO company dedicated to the screening of life - saving therapeutics to fight cancers. It is founded on a uniquely positioned paradigm: the use of a variety of experimental models that can accurately predict the clinical efficacy of new Investigational drugs (pharmaceutical leads).
Developing cutting - edge models (human solid tumor models) to screen innovative drugs for significant improvement of cancer treatment.

Drugs screening by tailoring the models to their mechanism of action. Evaluation of antitumor activity of selected agents/rational combinations, in human solid tumor models characterized in terms of expression of relevant targets.